MSP RECOVERY INC (LIFW) Stock Fundamental Analysis

NASDAQ:LIFW • US5537452097

3.24 USD
+1.65 (+103.77%)
At close: Dec 6, 2024
2.73 USD
-0.51 (-15.74%)
After Hours: 12/6/2024, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

LIFW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of LIFW have multiple concerns. LIFW is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • LIFW had negative earnings in the past year.
  • In the past year LIFW has reported a negative cash flow from operations.
LIFW Yearly Net Income VS EBIT VS OCF VS FCFLIFW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

  • LIFW has a Return On Assets of -3.49%. This is comparable to the rest of the industry: LIFW outperforms 44.95% of its industry peers.
  • With a Return On Equity value of -32.40%, LIFW is not doing good in the industry: 66.06% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIFW Yearly ROA, ROE, ROICLIFW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

  • The Gross Margin of LIFW (66.22%) is better than 88.99% of its industry peers.
  • In the last couple of years the Gross Margin of LIFW has declined.
  • LIFW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
LIFW Yearly Profit, Operating, Gross MarginsLIFW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • LIFW does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LIFW has been reduced compared to 1 year ago.
  • LIFW has a worse debt/assets ratio than last year.
LIFW Yearly Shares OutstandingLIFW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1B 2B 3B
LIFW Yearly Total Debt VS Total AssetsLIFW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of -1.22, we must say that LIFW is in the distress zone and has some risk of bankruptcy.
  • LIFW has a worse Altman-Z score (-1.22) than 81.65% of its industry peers.
  • LIFW has a Debt/Equity ratio of 2.54. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.54, LIFW is not doing good in the industry: 77.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.13%
LIFW Yearly LT Debt VS Equity VS FCFLIFW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

  • LIFW has a Current Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.01, LIFW is doing worse than 97.25% of the companies in the same industry.
  • LIFW has a Quick Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • LIFW has a Quick ratio of 0.01. This is amonst the worse of the industry: LIFW underperforms 97.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
LIFW Yearly Current Assets VS Current LiabilitesLIFW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for LIFW have decreased strongly by -1533.49% in the last year.
  • LIFW shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.67%.
  • Measured over the past years, LIFW shows a very negative growth in Revenue. The Revenue has been decreasing by -17.83% on average per year.
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LIFW Yearly Revenue VS EstimatesLIFW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2B 4B 6B
LIFW Yearly EPS VS EstimatesLIFW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • LIFW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 0.10, the valuation of LIFW can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than LIFW, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of LIFW to the average of the S&P500 Index (27.96), we can say LIFW is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.1
LIFW Price Earnings VS Forward Price EarningsLIFW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFW Per share dataLIFW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

  • LIFW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIFW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MSP RECOVERY INC

NASDAQ:LIFW (12/6/2024, 8:00:02 PM)

After market: 2.73 -0.51 (-15.74%)

3.24

+1.65 (+103.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners47.79%
Inst Owner Change0%
Ins Owners183.4%
Ins Owner Change0%
Market Cap21.25M
Revenue(TTM)10.73M
Net Income(TTM)-97.32M
Analysts82.86
Price Target3.06 (-5.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.1
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101.6
EYN/A
EPS(NY)31.2
Fwd EY963.02%
FCF(TTM)-4.41
FCFYN/A
OCF(TTM)-4.02
OCFYN/A
SpS1.64
BVpS45.78
TBVpS-376.77
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 23.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.22
F-Score3
WACC4.13%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.37%
OCF growth 3YN/A
OCF growth 5YN/A

MSP RECOVERY INC / LIFW FAQ

What is the ChartMill fundamental rating of MSP RECOVERY INC (LIFW) stock?

ChartMill assigns a fundamental rating of 1 / 10 to LIFW.


What is the valuation status of MSP RECOVERY INC (LIFW) stock?

ChartMill assigns a valuation rating of 4 / 10 to MSP RECOVERY INC (LIFW). This can be considered as Fairly Valued.


What is the profitability of LIFW stock?

MSP RECOVERY INC (LIFW) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for LIFW stock?

The Earnings per Share (EPS) of MSP RECOVERY INC (LIFW) is expected to grow by 264.17% in the next year.